CRISPR prime editing for unconstrained correction of oncogenic KRAS variants
This study develops universal pegRNAs for CRISPR prime editing to correct multiple KRAS mutations in cancer cells, achieving up to 54.7% correction efficiency in HEK293T/17 cells.
bioRxiv · Dec 21, 2022 · PreprintBioengineering